Two different NuNaturals sweeteners were given the second-highest risk warning by the FDA. Here's what that means.

In a clinical trial, the company's weight loss pill resulted in a nearly 12% weight loss at 72 weeks for participants who took the highest dose of the medication. On average, participants lost 7.8% to ...

Recently released results from a clinical trial on orforglipron show that the oral medication can cause impressive weight ...

Discover groundbreaking research from Harvard Medical School revealing lithium's critical role in brain health, aging and ...

The Food and Drug Administration (FDA) is launching a new program to ramp up the United States’s domestic pharmaceutical ...

Because price and margin headwinds exist predominantly in small-molecule oral tablets that are easy to produce, we expect Viatris’ pipeline to focus more on complex generics—drugs that have complex ...

On June 30, 2025, FDA’s Human Foods Program published its proposed 2025 guidance agenda, including the Agency’s priority ...

The Food and Drug Administration Aug. 7 announced a new program to help improve the domestic pharmaceutical supply chain by ...

Eli Lilly reported second quarter earnings Thursday, a day after competitor Novo Nordisk missed earnings estimates by Wall ...

Presbyopia is a common variant of farsightedness affecting over 128 million people in the US, including the majority of ...

The initiative is a response to a Trump administration order to speed the construction of the type of new drug factories many pharmaceutical companies have promised to build.